Aquestive Therapeutics, Inc. ($AQST)
Filing Information
| Accession Number | 0001214659-26-003144 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
200,311
Total Value
$427,372.80
P&L
+116.5% (+$374,750.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Regulatory Affairs | Common Stock | โ | Mar 9, 2026 | Grant/Award | 100,000 | $0.00 | $0.00 | 300,178 | Direct | โ | View Details | |
SVP, Regulatory Affairs | Common Stock | โ | Mar 10, 2026 | Sale | 25,311 | $4.17 | $105,622.80 | 274,867 | Direct | โ | View Details | |
SVP, Regulatory Affairs | Non-Qualified Stock Option (right to buy) | Derivative | Mar 9, 2026 | Grant/Award | 75,000 | $4.29 | $321,750.00 | 75,000 | Direct | โ | View Details |